Head and Neck Diseases by Alexandros G.Sfakianakis: Drug survival of secukinumab for moderate‐to‐severe plaque psoriasis: reply from authors

Δευτέρα 14 Μαΐου 2018

Drug survival of secukinumab for moderate‐to‐severe plaque psoriasis: reply from authors

British Journal of Dermatology, EarlyView.

https://ift.tt/2Kqxinp

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου